149 related articles for article (PubMed ID: 15053894)
1. Virally induced inflammation and therapeutic avenues in type 1 diabetes.
Christen U; Juedes A; Homann D; von Herrath MG
Endocrinol Metab Clin North Am; 2004 Mar; 33(1):45-58, viii. PubMed ID: 15053894
[No Abstract] [Full Text] [Related]
2. Role of viruses in type I diabetes.
von Herrath MG; Holz A; Homann D; Oldstone MB
Semin Immunol; 1998 Feb; 10(1):87-100. PubMed ID: 9529659
[TBL] [Abstract][Full Text] [Related]
3. Cytokines activate caspase-3 in insulinoma cells of diabetes-prone NOD mice directly and via upregulation of Fas.
Augstein P; Bahr J; Wachlin G; Heinke P; Berg S; Salzsieder E; Harrison LC
J Autoimmun; 2004 Dec; 23(4):301-9. PubMed ID: 15571924
[TBL] [Abstract][Full Text] [Related]
4. In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha.
Qin HY; Chaturvedi P; Singh B
Int Immunol; 2004 Dec; 16(12):1723-32. PubMed ID: 15492021
[TBL] [Abstract][Full Text] [Related]
5. Immunology. Policing the immune system.
Wickelgren I
Science; 2004 Oct; 306(5696):596-9. PubMed ID: 15498987
[No Abstract] [Full Text] [Related]
6. Immune cells, pancreas development, regeneration and type 1 diabetes.
Homo-Delarche F; Drexhage HA
Trends Immunol; 2004 May; 25(5):222-9. PubMed ID: 15099561
[No Abstract] [Full Text] [Related]
7. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
[TBL] [Abstract][Full Text] [Related]
8. Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2(s) congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes.
Greve B; Reddy J; Waldner HP; Sobel RA; Kuchroo VK
Eur J Immunol; 2004 Jul; 34(7):1828-38. PubMed ID: 15214031
[TBL] [Abstract][Full Text] [Related]
9. Autoimmunity. The pathogen connection.
Benoist C; Mathis D
Nature; 1998 Jul; 394(6690):227-8. PubMed ID: 9685154
[No Abstract] [Full Text] [Related]
10. A novel apoptosis-inducing anti-PSGL-1 antibody for T cell-mediated diseases.
Huang CC; Lu YF; Wen SN; Hsieh WC; Lin YC; Liu MR; Chiang E; Chang CN; Lin RH
Eur J Immunol; 2005 Jul; 35(7):2239-49. PubMed ID: 15948216
[TBL] [Abstract][Full Text] [Related]
11. Dynamic interaction between T cell-mediated beta-cell damage and beta-cell repair in the run up to autoimmune diabetes of the NOD mouse.
Vukkadapu SS; Belli JM; Ishii K; Jegga AG; Hutton JJ; Aronow BJ; Katz JD
Physiol Genomics; 2005 Apr; 21(2):201-11. PubMed ID: 15671250
[TBL] [Abstract][Full Text] [Related]
12. Lessons on autoimmune diabetes from animal models.
Yang Y; Santamaria P
Clin Sci (Lond); 2006 Jun; 110(6):627-39. PubMed ID: 16689681
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T-cells protect from type 1 diabetes after induction by coxsackievirus infection in the context of transforming growth factor-beta.
Richer MJ; Straka N; Fang D; Shanina I; Horwitz MS
Diabetes; 2008 May; 57(5):1302-11. PubMed ID: 18268045
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse.
Haskins K
Adv Immunol; 2005; 87():123-62. PubMed ID: 16102573
[TBL] [Abstract][Full Text] [Related]
15. Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice.
Koulmanda M; Bhasin M; Hoffman L; Fan Z; Qipo A; Shi H; Bonner-Weir S; Putheti P; Degauque N; Libermann TA; Auchincloss H; Flier JS; Strom TB
Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16242-7. PubMed ID: 18852471
[TBL] [Abstract][Full Text] [Related]
16. Insulin-dependent diabetes loci Idd5 and Idd9 increase sensitivity to experimental autoimmune encephalomyelitis.
Mayo S; Kohler W; Kumar V; Quinn A
Clin Immunol; 2006; 118(2-3):219-28. PubMed ID: 16301001
[TBL] [Abstract][Full Text] [Related]
17. NOD mice have a severely impaired ability to recruit leukocytes into sites of inflammation.
Bouma G; Nikolic T; Coppens JM; van Helden-Meeuwsen CG; Leenen PJ; Drexhage HA; Sozzani S; Versnel MA
Eur J Immunol; 2005 Jan; 35(1):225-35. PubMed ID: 15593124
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune diabetes mellitus--much progress, but many challenges.
McDevitt HO; Unanue ER
Adv Immunol; 2008; 100():1-12. PubMed ID: 19111161
[No Abstract] [Full Text] [Related]
19. Transient chemokine receptor blockade does not prevent, but may accelerate type 1 diabetes in prediabetic NOD mice.
Seifarth C; Mack M; Steinlicht S; Hahn EG; Lohmann T
Horm Metab Res; 2006 Mar; 38(3):167-71. PubMed ID: 16673207
[TBL] [Abstract][Full Text] [Related]
20. Microorganisms and autoimmunity: making the barren field fertile?
von Herrath MG; Fujinami RS; Whitton JL
Nat Rev Microbiol; 2003 Nov; 1(2):151-7. PubMed ID: 15035044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
